Canadian Medical Systems (CMS) is a Health Canada authorized leading medical manufacturing firm that provides a range of medical-grade devices and technology designed to meet the growing public and private sector demand for COVID-19 solutions. Headquartered in Toronto, Canada with representatives and distributors in the U.S. and United Arab Emirates (UAE), CMS welcomes government agencies, private corporations, and innovators to join together in the global effort to develop new products and solutions for a better world. CMS only offers products that are proprietary of CMS where it holds a patent and / or a patent pending status in the U.S. and Canada. As such, no third party(s) offering similar products have been licenced by CMS unless duly named on CMS' website. In certain cases, CMS accepts master distribution licensing of products that are focused on helping Canadians in times of crisis. Currently, this is limited to the Mutual Supply and Distribution Agreement with the Advanced Biocide Technologies of the United States. Study and research has shown that approximately 20% of virus transmissions and diseases are contracted through external factors*, and CMS’ solutions are tailored to mitigate the risk of external transmission where people are most vulnerable.